Article Details

Seelos Therapeutics Announces Positive In Vivo Data Demonstrating Down-Regulation of SNCA ...

Retrieved on: 2021-07-07 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Seelos Therapeutics Announces Positive In Vivo Data Demonstrating Down-Regulation of SNCA .... View article details on hiswai:

Excerpt

A reduction of 25%-50% in SNCA mRNA and protein expression should be sufficient to restore normal physiological levels of SNCA. "We are highly ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up